B. Kim

Risk factors for disease progression in COVID-19 patients

M. Chang, Donghwi Park, Yukyung Park, 2020, BMC Infectious Diseases.

Use of combined treatment of 3rd-generation cephalosporin, azithromycin and antiviral agents on moderate SARs-CoV-2 patients in South Korea: A retrospective cohort study

Yukyung Park, B. Kim, Sung-Kyu Park, 2022, PloS one.

Risk Factors for Progression to Patients with Severe Stage of COVID-19

M. Chang, Donghwi Park, B. Kim, 2020 .

Treatment Response to Hydroxychloroquine, Lopinavir–Ritonavir, and Antibiotics for Moderate COVID-19: A First Report on the Pharmacological Outcomes from South Korea

Min Ho An, Woorim Kim, Min Seo Kim, 2020 .

Clinical Characteristics and Outcomes of COVID-19 Cohort Patients in Daegu Metropolitan City Outbreak in 2020

T. Park, Yu Mi Lee, S. Kim, 2020, Journal of Korean medical science.

Patterns of viral clearance in the natural course of asymptomatic COVID-19: Comparison with symptomatic non-severe COVID-19

J. Uhm, Hyeong-Nyeon Kim, Ho-sung Yi, 2020, International Journal of Infectious Diseases.